ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ: SPRY · Real-Time Price · USD
7.89
-0.30 (-3.66%)
At close: Jul 8, 2026, 4:00 PM EDT
8.19
+0.30 (3.80%)
After-hours: Jul 8, 2026, 6:23 PM EDT
ARS Pharmaceuticals Market Cap
ARS Pharmaceuticals has a market cap or net worth of $783.5 million as of July 8, 2026. Its market cap has decreased by -51.86% in one year.
Market Cap
783.50M
Enterprise Value
774.58M
1-Year Change
-51.86%
Ranking
Category
Stock Price
$7.89
Market Cap Chart
Since November 9, 2022, ARS Pharmaceuticals's market cap has increased from $568.25M to $783.50M, an increase of 37.88%. That is a compound annual growth rate of 9.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 8, 2026 | 783.50M | -31.96% |
| Dec 31, 2025 | 1.15B | 12.32% |
| Dec 31, 2024 | 1.03B | 94.90% |
| Dec 29, 2023 | 526.06M | -34.23% |
| Dec 30, 2022 | 799.86M | 40.76% |
| Nov 9, 2022 | 568.25M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Theravance Biopharma | 876.40M |
| Oculis Holding AG | 833.36M |
| Tenax Therapeutics | 830.75M |
| CytomX Therapeutics | 829.45M |
| Zevra Therapeutics | 825.84M |
| Odyssey Therapeutics | 788.79M |
| Aura Biosciences | 782.02M |
| Aclaris Therapeutics | 766.75M |